KLC2

kinesin light chain 2, the group of Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 11:66257294-66267860

Links

ENSG00000174996NCBI:64837OMIM:611729HGNC:20716Uniprot:Q9H0B6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spastic paraplegia, optic atropy, and neuropathy (Limited), mode of inheritance: AR
  • spastic paraplegia, optic atropy, and neuropathy (Supportive), mode of inheritance: AR
  • spastic paraplegia, optic atropy, and neuropathy (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spastic paraplegia, optic atrophy, and neuropathyARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal; Neurologic26385635

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KLC2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLC2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
23
clinvar
5
clinvar
28
missense
58
clinvar
3
clinvar
2
clinvar
63
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
2
6
non coding
5
clinvar
4
clinvar
9
Total 0 0 59 31 11

Variants in KLC2

This is a list of pathogenic ClinVar variants found in the KLC2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-66258602-T-C not specified Likely benign (Apr 18, 2023)2538354
11-66258604-A-T Uncertain significance (Jul 17, 2022)1970480
11-66258624-G-A Likely benign (Jun 01, 2024)1596624
11-66258654-C-T Likely benign (Nov 01, 2022)2641982
11-66258714-T-C Likely benign (Mar 01, 2024)3067594
11-66258720-G-A Benign (Jan 13, 2024)781008
11-66258730-G-C Uncertain significance (Sep 27, 2022)2022921
11-66258790-G-A not specified Uncertain significance (Oct 26, 2022)2319317
11-66258814-G-A not specified Uncertain significance (Dec 27, 2023)3115219
11-66261741-G-A Uncertain significance (Jan 01, 2023)2641983
11-66261776-T-C not specified Uncertain significance (Oct 12, 2021)2254433
11-66261800-G-A Uncertain significance (Jun 23, 2021)1491124
11-66261804-G-A Benign (Dec 31, 2023)719746
11-66261824-A-G not specified Uncertain significance (Jun 07, 2024)3288786
11-66261843-T-G Likely benign (Jun 21, 2021)1669364
11-66261882-T-G not specified Uncertain significance (Jan 09, 2024)2609318
11-66261891-C-T Likely benign (Jun 21, 2022)2418452
11-66261892-G-A not specified Uncertain significance (Jun 17, 2024)3288783
11-66261916-C-G Uncertain significance (May 19, 2022)2176600
11-66261944-G-A not specified Uncertain significance (May 23, 2023)2550376
11-66261947-A-G Uncertain significance (Nov 05, 2021)1492027
11-66262117-T-C Benign (Aug 28, 2023)797838
11-66262157-A-G Uncertain significance (Feb 22, 2023)2974278
11-66262159-G-A not specified Uncertain significance (Apr 16, 2024)3288785
11-66262160-A-T Uncertain significance (Jan 06, 2024)2694428

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KLC2protein_codingprotein_codingENST00000417856 1510567
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9750.02491257240181257420.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.022853980.7150.00002574001
Missense in Polyphen78132.970.586591313
Synonymous0.7041511620.9300.000009721258
Loss of Function4.55533.40.1500.00000171375

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002100.000210
Ashkenazi Jewish0.0001010.0000992
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00009070.0000879
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. The light chain may function in coupling of cargo to the heavy chain or in the modulation of its ATPase activity (By similarity). {ECO:0000250}.;
Disease
DISEASE: Spastic paraplegia, optic atrophy, and neuropathy (SPOAN) [MIM:609541]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPOAN is characterized by spastic paraplegia with progressive joint contractures and spine deformities, loss of independent ambulation by age 10 years, sub-normal vision secondary to congenital optic atrophy, and neuropathy. Inheritance is autosomal recessive. {ECO:0000269|PubMed:26385635}. Note=The gene represented in this entry is involved in disease pathogenesis. The disease is caused by a homozygous deletion in the non-coding region of the KLC2 gene. {ECO:0000269|PubMed:26385635}.;
Pathway
Salmonella infection - Homo sapiens (human);Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;RHO GTPases activate KTN1;Kinesins;Factors involved in megakaryocyte development and platelet production;RHO GTPase Effectors;Signaling by Rho GTPases;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.118

Intolerance Scores

loftool
0.380
rvis_EVS
-0.93
rvis_percentile_EVS
9.55

Haploinsufficiency Scores

pHI
0.265
hipred
Y
hipred_score
0.698
ghis
0.618

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.589

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Klc2
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype;

Zebrafish Information Network

Gene name
klc2
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
kinked

Gene ontology

Biological process
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II
Cellular component
nucleoplasm;mitochondrion;cytosol;kinesin complex;microtubule;plasma membrane;membrane;kinesin I complex;protein-containing complex
Molecular function
microtubule motor activity;protein binding;kinesin binding;cadherin binding